Lobbying Filing Details

Total Spending

$60,000

Activities

1

Lobbyists

2

Gov't Entities

2

Filing Information
Filing UUID:
047beba8-87db-4b34-ab45-104d087af7e3
Type:
Q1 - 1st Quarter - Report
Period:
2026 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 20, 2026 at 6:35 PM
Income:
$60,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Sarah Egge
Registrant
SPLITOAK STRATEGIES LLC

Health care consulting

Washington, District of Columbia
Client
ALNYLAM PHARMACEUTICALS, INC.

Biopharmaceutical company

Massachusetts, United States of America
Lobbying Activities (1)
Activity 1
Medicare/Medicaid

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; P.L. 119-21; U.S. Competitiveness

Lobbyists (2)
  • AMY JENSEN
  • SARAH KUEHL EGGE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 18, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.